找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biochemistry of Cardiovascular Dysfunction in Obesity; Paramjit S. Tappia,Sukhwinder K. Bhullar,Naranjan Book 2020 Springer Nature Switze

[复制链接]
楼主: ISH
发表于 2025-3-28 17:06:12 | 显示全部楼层
Inflammation and Epicardial Adipose Tissue in the Pathobiology of Atherogenesis and Neointimal Hyperective therapeutic interventions and preventive strategies. The basic and applied research have significantly advanced the understanding on the molecular pathology of CHDs and opened multiple translational avenues in the management. Despite the significant enhancement of knowledge in the underlying
发表于 2025-3-28 19:10:19 | 显示全部楼层
发表于 2025-3-29 01:28:22 | 显示全部楼层
Obesity and Cardiovascular Disease: Impact of Resveratrol as a Therapeuticcongestive heart failure. Increased adiposity is the hallmark of this physiological alteration of the body in response to excess intake of energy rich food, and this condition has far reaching health consequences in humans. Adipose dysfunction develops over time leading to increased secretion of inf
发表于 2025-3-29 06:14:34 | 显示全部楼层
发表于 2025-3-29 07:23:27 | 显示全部楼层
发表于 2025-3-29 14:16:31 | 显示全部楼层
Book 2020Cardiovascular Dysfunction in obesity (9 chapters).  . .Theintent of this volume is to provide current and basic understanding of the biochemical mechanisms of obesity induced cardiovascular dysfunction that will be of value not only to cardiologists and other allied health professionals, but will a
发表于 2025-3-29 18:33:21 | 显示全部楼层
Biochemistry of Cardiovascular Dysfunction in Obesity
发表于 2025-3-29 19:43:29 | 显示全部楼层
发表于 2025-3-30 02:44:59 | 显示全部楼层
,Kosten- und Erlösartenrechnung, direct role of LXR agonist in various cardiovascular diseases like atherosclerosis, myocardial infarction, diabetic cardiomyopathy, cardiac hypertrophy, fibrosis. These accumulating evidences support that LXRs may represent a novel potential therapeutic target for various cardiovascular diseases.
发表于 2025-3-30 04:28:13 | 显示全部楼层
Olaf Plötner,Tyge -F. Kummer,Barbara Sieben modalities in obesity induced cardiovascular diseases. We review various NLRP3 inflammasome-targeted strategies and the evidence supporting the role of the NLRP3 inflammasome in obesity induced cardiovascular complications such as atherosclerosis, hypertension, myocardial infarction and adverse car
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 16:11
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表